13-30763972-A-G
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_001629.4(ALOX5AP):āc.352A>Gā(p.Ile118Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000217 in 1,614,140 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_001629.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ALOX5AP | NM_001629.4 | c.352A>G | p.Ile118Val | missense_variant | 5/5 | ENST00000380490.5 | NP_001620.2 | |
ALOX5AP | NM_001204406.2 | c.523A>G | p.Ile175Val | missense_variant | 6/6 | NP_001191335.1 | ||
ALOX5AP | XM_017020522.3 | c.232A>G | p.Ile78Val | missense_variant | 5/5 | XP_016876011.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ALOX5AP | ENST00000380490.5 | c.352A>G | p.Ile118Val | missense_variant | 5/5 | 1 | NM_001629.4 | ENSP00000369858.3 | ||
ALOX5AP | ENST00000617770.4 | c.523A>G | p.Ile175Val | missense_variant | 6/6 | 1 | ENSP00000479870.1 |
Frequencies
GnomAD3 genomes AF: 0.000315 AC: 48AN: 152168Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.000227 AC: 57AN: 251304Hom.: 0 AF XY: 0.000199 AC XY: 27AN XY: 135828
GnomAD4 exome AF: 0.000207 AC: 302AN: 1461854Hom.: 0 Cov.: 30 AF XY: 0.000242 AC XY: 176AN XY: 727224
GnomAD4 genome AF: 0.000315 AC: 48AN: 152286Hom.: 0 Cov.: 33 AF XY: 0.000242 AC XY: 18AN XY: 74468
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 06, 2022 | The c.523A>G (p.I175V) alteration is located in exon 6 (coding exon 6) of the ALOX5AP gene. This alteration results from a A to G substitution at nucleotide position 523, causing the isoleucine (I) at amino acid position 175 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
ALOX5AP-related disorder Uncertain:1
Uncertain significance, no assertion criteria provided | clinical testing | PreventionGenetics, part of Exact Sciences | Jul 26, 2024 | The ALOX5AP c.352A>G variant is predicted to result in the amino acid substitution p.Ile118Val. To our knowledge, this variant has not been reported in the literature. This variant is reported in 0.096% of alleles in individuals of Ashkenazi Jewish descent in gnomAD. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at